
Injective Protocol is poised to achieve new heights this year, with prospects of hitting a new all-time high. As per the predictions, the INJ price may even reclaim the impressive $50 mark within the period from 2025 to 2030. Recently, Qubetics sold over 497 million tokens, associating with Injective to strengthen the DeFi system. Aptos remains leading in speed.
Deutsche Telekom associate has shown interest in the Injective blockchain by becoming a validator. An INJ price reversal is predicted consequent to Deutsche Telekom backing Injective Crypto. Injective 3.0 has launched with a primary focus on reducing the Injective (INJ) token supply, a move that may spur an INJ rally amid the promise of a deflationary environment.
Injective is partnered with io.net to develop advanced AI models utilizing decentralized infrastructure. The cryptosphere marks Injective as one of the top cryptos to procure now, promising big returns in 2025. Among other important steps, Injective Protocol is all set to introduce the S&P 500 Index on February 10th, and it is speculated that the INJ price may surge following the onset of the new INJ 3.0 era.
Agora's AUSD has been inducted as Injective's first native stablecoin. Further, according to an expert prediction, AI Cryptos like Injective and INTL are likely to see a 10x surge once Bitcoin touches $100k again. In a strategic move, Injective is integrating with the TON Blockchain Ecosystem and is collaborating with Sonic for the inception of a crosschain AI agent hub.
Injective also confirmed the start of on-chain AI agents for public access. The crypto ecosystem has welcomed this as a promising sign for the evolution of DeFi.
Injective Coin News Analytics from Mon, 07 Nov 2022 21:11:30 GMT to Mon, 10 Mar 2025 11:40:00 GMT - Rating 8 - Innovation 10 - Information 7 - Rumor -7